ArticleCase reports in gastroenterology
Mesenteric Hyperperfusion Syndrome following Endovascular Treatment of Chronic Mesenteric Ischemia: A Case Report.
Article in Case reports in gastroenterology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Revascularization for chronic mesenteric ischemia is generally well tolerated, yet some patients experience acute multisystem deterioration afterward. The term reperfusion syndrome, commonly used in the context of acute ischemia, is often incorrectly applied to chronic disease. Case Presentation: We present a case of hyperperfusion syndrome following successful two-vessel stenting in a patient with chronic mesenteric ischemia, complicated by ascites and supported by imaging and laboratory findings. Our report also highlights new-onset thrombocytopenia as part of the clinical picture. The syndrome resolved spontaneously with supportive care. Conclusion: Clinicians should remain alert to hyperperfusion phenomena in chronic cases, particularly after simultaneous two-vessel revascularization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.